Harvard Medical School Center for Neurofibromatosis and Allied Disorders

The Center for Neurofibromatosis and Allied Disorders (CNfAD) aims to understand the mechanisms that cause neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) and to develop and test rational treatments for these disorders. We also focus on several allied disorders, such as schwannomatosis, multiple familial meningiomas and multiple familial neurofibromas, that have features similar to NF but are not due to inherited mutations in the NF1 or NF2 genes. The CNfAD facilitates interdisciplinary approaches to research and promotes cooperative clinical studies between Harvard Medical School affiliated institutions as it aims to bridge the gap between clinical and basic scientists to gain the synergies that result from directly relating studies of humans with those in experimental models.

Registration information is now available. Please click here to download a PDF version of the brochure. If you cannot view the brochure please contact administrator@cnfad.org or call 1-800-956-6759 and request that a brochure be sent to you.

Mission

2011 Neurofibromatosis and Allied Disorders Symposium